Skip Navigation

Your Environment. Your Health.

Selected Publications

Environmental Autoimmunity Group

2014

  1. Mahler M, Miller FW, Fritzler MJ. Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review. Autoimmunity reviews 2014 13(4-5):367-371.[Abstract ]
  2. Dinse GE, Jusko TA, Ho LA, Annam K, Graubard BI, Hertz-Picciotto I, Miller FW, Gillespie BW, Weinberg CR. Accommodating measurements below a limit of detection: a novel application of cox regression. American journal of epidemiology 2014 179(8):1018-1024.[Abstract ]
  3. Aggarwal R, Bandos A, Reed AM, Ascherman DP, Barohn RJ, Feldman BM, Miller FW, Rider LG, Harris-Love MO, Levesque MC, RIM Study Group, Oddis CV. Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis. Arthritis & rheumatology (Hoboken, N.J.) 2014 66(3):740-749.[Abstract ]

2013

  1. Rider LG, Katz JD, Jones OY. Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies. Rheumatic diseases clinics of North America. 2013 39(4):877-904.[Abstract ]
  2. Mamyrova G, Katz JD, Jones RV, Targoff IN, Lachenbruch PA, Jones OY, Miller FW, Rider LG, Childhood Myositis Heterogeneity Collaborative Study Group. Clinical and laboratory features distinguishing juvenile polymyositis and muscular dystrophy. Arthritis Care Res (Hoboken) 2013 65(12):1969-75.[Abstract ]
  3. Razzaghian HR, Forsberg LA, Prakash KR, Przerada S, Paprocka H, Zywicka A, Westerman MP, Pedersen NL, O'Hanlon TP, Rider LG, Miller FW, Srutek E, Jankowski M, Zegarski W, Piotrowski A, Absher D, Dumanski JP. Post-zygotic and inter-individual structural genetic variation in a presumptive enhancer element of the locus between the IL10Rβ and IFNAR1 genes. PloS one 2013 8(9):e67752-.[Abstract ]
  4. Miller FW, Cooper RG, Vencovsky J, Rider LG, Danko K, Wedderburn LR, Lundberg IE, Pachman LM, Reed AM, Ytterberg SR, Padyukov L, Selva-O'Callaghan A, Radstake T, Isenberg DA, Chinoy H, Ollier WE, O'Hanlon TP, Peng B, Lee A, Lamb JA , Chen W, Amos CI, Gregersen PK, Myositis Genetics Consortium. Genome-wide association study of dermatomyositis reveals genetic overlap with other autoimmune disorders. Arthritis and rheumatism 2013 65(12):3239-3247.[Abstract ]
  5. Shah M, Targoff IN, Rice MM, Miller FW, Rider LG, Childhood Myositis Heterogeneity Collaborative Study Group. Brief report: ultraviolet radiation exposure is associated with clinical and autoantibody phenotypes in juvenile myositis. Arthritis and Rheumatism 2013 65(7):1934-1941.[Abstract ]
  6. Shah M, Mamyrova G, Targoff IN, Huber AM, Malley JD, Rice MM, Miller FW, Rider LG, with the Childhood Myositis Heterogeneity Collaborative Study Group. The Clinical Phenotypes of the Juvenile Idiopathic Inflammatory Myopathies. Medicine 2013 92(1):25-41.[Abstract ]
  7. Parks CG, D'Aloisio AA, DeRoo LA, Huiber K, Rider LG, Miller FW, Sandler DP. Childhood socioeconomic factors and perinatal characteristics influence development of rheumatoid arthritis in adulthood. Ann Rheum Dis. 2013 Mar;72(3):350-6.[Abstract ]
  8. Oddis CV, Reed AM, Aggarwal R, Rider LG, Ascherman DP, Levesque MC, Barohn RJ, Feldman BM, Harris-Love MO, Koontz DC, Fertig N, Kelley SS, Pryber SL, Miller FW, Rockette HE; RIM Study Group. Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial. Arthritis Rheum. 2013 Feb;65(2):314-24.[Abstract ]
  9. Lazarevic D, Pistorio A, Palmisani E, Miettunen P, Ravelli A, Pilkington C, Wulffraat NM, Malattia C, Garay SM, Hofer M, Quartier P, Dolezalova P, Penades IC, Ferriani VP, Ganser G, Kasapcopur O, Melo-Gomes JA, Reed AM, Wierzbowska M, Rider LG, Martini A, Ruperto N; Paediatric Rheumatology International Trials Organisation (PRINTO). The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis. Ann Rheum Dis. 2013 May;72(5):686-93.[Abstract ]

2012

  1. Forsberg1 LA, Rasi C , Razzaghian HR, Pakalapati G, Waite L , Thibeault C , Ronowicz A , Wineinger NE , Tiwari HE, Boomsma D , Westerman MP, Harris JR , Lyle R , Essand M, Eriksson F , Assimes TL, Iribarren C, Strachan E, OHanlon TR, Rider LG, Miller FW, Giedraitis V , Lannfelt L, Ingelsson M , Piotrowski A, Pedersen NL, Absher D , Dumanski JP. Age-related somatic structural changes in the nuclear genome of human blood cells. American Journal of Human Genetics 2012 90(2):217-228. [Abstract ]
  2. Miller FW, Pollard KM, Parks CG, Germolec DR, Leunge PS, Selmi C, Humble MC, Rose NR. Criteria for environmentally associated autoimmune diseases. Journal of autoimmunity 2012 39(4):253-8[Abstract ]
  3. Arabshahi B, Silverman RA, Jones OY, Rider LG. Abatacept and Sodium Thiosulfate for Treatment of Recalcitrant Juvenile Dermatomyositis Complicated by Ulceration and Calcinosis.The Journal of pediatrics 2012 160(3):520-2.[Abstract ]
  4. Miller FW. New Approaches to the Assessment and Therapy of the Idiopathic Inflammatory Myopathies. Annals of the rheumatic diseases 2012 71(Suppl 2):i82-5.[Abstract ]
  5. Satoh M, Chan EK, Ho LA, Rose KM, Parks CG, Cohn RD, Jusko TA, Walker NJ, Germolec DR, Whitt IZ, Crockett PW, Pauley BA, Chan JY, Ross SJ, Birnbaum LS, Zeldin DC, Miller FW. Prevalence and Sociodemographic Correlates of Anti-nuclear Antibodies In the United States. Arthritis and rheumatism 2012 64(7):2319-27.[Abstract ]
  6. Volochayev R, Csako G, Wesley R, Rider LG, Miller FW. Laboratory Test Abnormalities are Common in Polymyositis and Dermatomyositis and Differ Among Clinical and Demographic Groups. The open rheumatology journal 2012 6:54-63.[Abstract ]
  7. Miller FW , Alfredsson L, Costenbader KH, Kamen DL, Nelson LM, Norris JM, De Roos AJ. Epidemiology of environmental exposures and human autoimmune diseases: Findings from a National Institute of Environmental Health Sciences Expert Panel Workshop. Journal of autoimmunity 2012 39(4):259-71.[Abstract ]

2011

  1. Gan L, Miller FW. State of the art: what we know about infectious agents and myositis. Current opinion in rheumatology 2011 23(6):585-94. [Abstract ]
  2. Rider LG, Werth VP, Huber AM, Alexanderson H, Rao AP, Ruperto N, Herbelin L, Barohn R, Isenberg D, Miller FW. Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI). Arthritis care & research 2011 63(Suppl 11):S118-57.[Abstract ]
  3. Allen JA, Peterson A, Sufit R, Hinchcliff ME, Mahoney JM, Wood TA, Miller FW, Whitfield ML, Varga J. Post-epidemic eosinophilia myalgia syndrome associated with L-Tryptophan. Arthritis Rheum 2011; 61(11):3633-3639.[Abstract ]
  4. O'Hanlon TP, Rider LG, Gan L, Fannin R, Paules RS, Umbach DM, Weinberg CR, Shah RR, Mav D, Gourley MF, Miller FW. Gene Expression Profiles from Discordant Monozygotic Twins Suggest that Molecular Pathways are Shared Among Multiple Systemic Autoimmune Diseases. Arthritis research & therapy 2011; 13(2):R69-.[Abstract ]  
  5. Perdivara I, Peddada SD, Miller FW , Tomer KB, Deterding LJ, Mass spectrometric determination of IgG subclass-specific glycosylation profiles in siblings discordant for myositis syndromes. Journal of proteome research 2011; 10(7):2969-2978. [Abstract] 

  6. Katz JD, Mamyrova G, Agarwal S, Jones OY, Bollar H, Huber AM, Rider LG, White PH, Parents' perception of self-advocacy of children with myositis: an anonymous online survey. Pediatric Rheumatology 2011; 9:10. [Abstract] 

  7. Rider LG, Miller FW, Deciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies. JAMA 2011; 305(2):183-190. [Abstract] 

 

2010

  1. Rider LG, Wu L, Mamyrova G, Targoff IN, Miller FW, Environmental Factors Preceding Illness Onset Differ in Phenotypes of the Juvenile Idiopathic Inflammatory Myopathies. Rheumatology (Oxford, England) 2010; 2381-2390. [Abstract] 

  2. Ruperto N, Pistorio A, Ravelli A, Rider L, Pilkington C, Oliveira S, Wulffraat N, Espada G, Garay S, Cuttica R, Hofer M, Quartier P, Melo-Gomes J, Reed AM, Wierzbowska M, Feldman BM, Harjacek M, Huppertz HI, Nielsen S, Flato B, Lahdenne P, Michels H, Murray KJ, Punaro L, Rennebohm R, Russo R, Balogh Z, Rooney M, Pachman LM, Wallace C, Hashkes P, Lovell DJ, Giannini EH, Martini A, for the Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG), The Paediatric Rheumatology International Trials Organisation provisional criteria for the evaluation of response to therapy in juvenile dermatomyositis. Arthritis care and research 2010; 62(11):1533-1541. [Abstract] 

  3. Resnik D, Miller F, The ethics of sham surgery on research subjects with cognitive impairments that affect decision-making capacity. Contemporary clinical trials. 2010; 31(5):407-410. [Abstract] 

  4. Rider LG, Miller FW, Mast Cells and Type I Interferon Responses in the Skin of Juvenile Dermatomyositis: Are Current Therapies Just Scratching the Surface?. Arthritis and rheumatism 2010; 62(9):2619-2622. [Abstract] 

  5. Huber AM, Giannini E, Bowyer SL, Kim S, Lang B, Lindsley C, Pachman LM, Pilkington C, Reed AM, Rennebohm R, Rider LG, Wallace C, Feldman BM, Protocols for the treatment of moderately-severe juvenile dermatomyositis: Results of a children's arthritis and rheumatology research alliance consensus conference. Arthritis care and research 2010; 62(2):219-225. [Abstract] 

  6. Rider LG, Koziol D, Giannini EH, Jain MS, Smith MR, Whitney-Mahoney K, Feldman BM, Wright SJ, Lindsley CB, Pachman LM, Villalba ML, Lovell DJ, Bowyer SL, Plotz PH, Miller FW, Hicks JE, Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathies. Arthritis care and research 2010; 62(4):465-472. [Abstract] 

 

2009

  1. Wedderburn LR, Rider LG. Juvenile Dermatomyositis: New Developments in Pathogenesis, Assessment and Treatment. Best practice & research. Clinical rheumatology 2009 23(5):665-78.[Abstract ]
  2. Lachenbruch PA, Miller FW, Rider LG, On determining the effects of therapy on disease damage in non-randomized studies with multiple treatments: A study of juvenile myositis. Communications in Statistics - Theory and Methods 2009; 38(18):3268-3281.

  3. Coye K, Rother KI, Weise M, Ahmed A, Miller FW, Rider LG, Metabolic Abnormalities and Cardiovascular Risk Factors in Children with Myositis. The Journal of pediatrics 2009; 155(6):882-887. [Abstract] 

  4. Ball R, Shadomy SS, Meyer A, Huber B, Leffell MS, Zachary A, Belotto M, Hilton E, Bryant-Genevier M, Schriefer ME, Miller FW, Braun MM, HLA type and immune response to Borrelia burgdorferi outer surface protein a in people in whom arthritis developed after Lyme disease vaccination. Arthritis and rheumatism 2009; 60(4):1179-1186. [Abstract] 

  5. Harris-Love MO, Shrader JA, Koziol D, Pahlajani N, Jain M, Smith M, Cintas HL, McGarvey CL, James-Newton L, Pokrovnichka A, Moini R, Cabalar I, Lovell DJ, Wesley R, Plotz PH, Miller FW, Hicks JE, Rider LG, Distribution and severity of weakness among polymyositis, dermatomyositis and juvenile dermatomyositis. Rheumatology 2009; 48(2):134-139. [Abstract] 

  6. Rider LG, Atkinson JC, Images in clinical medicine. Gingival and periungual vasculopathy of juvenile dermatomyositis. The New England journal of medicine 2009; 360(15):e21-. [Abstract] 

  7. Dugan EM, Huber A, Miller FW, Rider LG, Photoessay of the cutaneous manifestations of the idiopathic inflammatory myopathies. Dermatology online journal 2009; 15(2):1. [Abstract] 

  8. Love LA, Weinberg C, McConnaughey DR, Oddis CV, Medsger T, Reveille J, Arnett FC, Targoff IN, Miller FW, Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women. Arthritis and rheumatism 2009; 60(8):2499-2504. [Abstract] 

  9. Okada S, Kamb ML, Pandey JP, Philan RM, Love LA, Miller FW, Immunogenetic risk and protective factors for development of L-tryptophan-associated Eosinophilia-Myalgia Syndrome and associated symptoms. Arthritis and rheumatism 2009; 61(10):1305-1311. [Abstract] 

  10. Eidelman N, Boyde A, Bushby AJ, Howell PGT, Sun J, Newbury DE, Miller FW, Robey PG, Rider LG, Microstructure and mineral composition of dystrophic calcification associated with the idiopathic inflammatory myopathies. Arthritis research and therapy 2009; 11(5):R159-. [Abstract] 

 

2008

  1. O'Hanlon TP, Rider LG, Schiffenbauer A, Targoff IN, Malley JK, Pandey JP, Miller FW, Immunoglobulin gene polymorphisms are susceptibility factors in clinical and autoantibody subgroups of the idiopathic inflammatory myopathies. Arthritis and rheumatism 2008; 58(10):3239-3246. [Abstract] 

  2. Bingham A, Mamyrova G, Rother KI, Oral E, Cochran E, Premkumar A, Kleiner D, James-Newton L, Targoff IN, Pandey JP, Carrick DM, Sebring N, O'Hanlon TP, Ruiz-Hidalgo MR, Turner M, Gordon LB, Laborda J, Bauer S, Blackshear PJ, Phil D, Imundo L, Miller FW, Rider LG, Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity. Medicine 2008; 87(2):70-86. [Abstract] 

  3. Huber AM, Lachenbruch PA, Dugan EM, Miller FW, Rider LG, Alternative scoring of the Cutaneous Assessment Tool (CAT) in juvenile dermatomyositis: results using an abbreviated format. Arthritis care and research : the official journal of the Arthritis Health Professions Association 2008; 59(3):352-356. [Abstract] 

  4. Rider LG, Leschek EW, Does early growth hormone therapy prevent glucocorticoid-associated growth retardation in children with JIA? Commentary on article by Simon et. al.. Nature clinical practice.. Rheumatology 2008; 4(3):394-395. [Abstract] 

  5. Rider LG, Lachenbruch PA, Isenberg D, Miller FW, Applicability of the paediatric rheumatology international trials organisation disease activity core set for juvenile dermatomyositis: Comment on the article by Ruperto et al... Arthritis care and research : the official journal of the Arthritis Health Professions Association 2008; 59(8):1197-1198. [Abstract] 

  6. Mamyrova G, O'Hanlon TP, Sillers L, Malley K, James-Newton L, Parks CG, Cooper GS, Pandey JP, Miller FW, Rider LG, Cytokine gene polymorphisms as risk and severity factors for juvenile dermatomyositis. Arthritis and rheumatism 2008; 58(12):3941-3950. [Abstract] 

 

2007

  1. Csako G, Costello R, Shamim EA, O'Hanlon TP, Tran A, Clauw D, Williams HJ, Miller FW, Serum proteins and paraproteins in women with silicone implants and connective tissue disease - A case-control study. Arthritis research & therapy 2007; 9(5):R95-. [Abstract] 

  2. Gourley, M and Miller, FW, Mechanisms of Disease: Environmental Factors in the Pathogenesis of Rheumatic Disease. Nature Clinical Practice Rheumatology 2007; 3:172-180.

  3. Vegosen, L, Weinberg, C, O'Hanlon, T, Targoff, I, Koneru, B, Mamyrova, G, Miller, FW, Rider, L, Seasonal birth patterns suggest a role for perinatal environmental factors in the etiology of subgroups of myositis. Arthritis Rheum 2007; 56:2729-2739. [Abstract] 

  4. Huber, AM, Dugan, EM, Lachenbruch, PA, Feldman, BM, Perez, MD, Zemel, LS, Lindsley, CB, Rennebohm, RM, Wallace, CA, Passo, MH, Reed, AM, Bowyer, SL, Ballinger, SH, Miller, FW, Rider, LG, The Cutaneous Assessment Tool (CAT): development and reliability in juvenile idiopathic inflammatory myopathy. Rheumatism 2007; 10:1606-1611. [Abstract] 

 

2006

  1. O'Hanlon, TP, Mercatante-Carrick, D, Targoff, IN, Arnett, FC, Reveille, J, Carrington, M, Gao, X, Oddis, CV, Morel, P, Malley, JD, Malley, K, Shamim, E, Rider, LG, Chanock, SJ, Foster, C, Bunch, T, Blackshear, PJ, Plotz, PH, Love, LA, Miller, FW, Immunogenetic Risk and Protective Factors for the Idiopathic Inflammatory Myopathies: Distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 Allelic Profiles Distinguish European American Patients With Different Myositis Autoantibodies. Medicine (Baltimore) 2006; 85(2):111-127.

  2. Targoff, IN, Mamyrova, G, Trieu, E, Perurena, O, Koneru, B, O'Hanlon, YP, Miller, FW*, Rider, LG*, for the Childhood Myositis Heterogeneity and International Myositis Collaborative Study Groups, A novel autoantibody to a 155 kd protein is associated with dermatomyositis. Arthritis Rheum 2006; 54:3682-3689.

  3. O'Hanlon, TP, Rider, LG, Mamyrova, G, Targoff, IN, Arnett, FC, Reveille, J, Carrington, M, Gao, X, Oddis, CV, Morel, P, Malley, JD, Malley, K, Shamim, E, Chanock, SJ, Foster, C, Bunch, T, Plotz, PH, Love, LA, Miller, FW, HLA Polymorphisms in African Americans with Idiopathic Inflammatory Myopathies: Allelic profiles distinguish patients with different clinical phenotypes and myositis autoantibodies. Arthritis Rheum 2006; 54:3670-3681.

  4. Mamyrova G, O'Hanlon TP, Monroe J, Mercatante Carrick D, Malley J, Adams S, Reed AM, Shamim E, James Newton L, Miller FW, Rider LG, for the Childhood Myositis Heterogeneity Collaborative Study Group, Immunogenetic risk and protective factors for juvenile dermatomyositis in Caucasian patients. Arthritis Rheum 2006; 54:3979-3987.

  5. Römisch, K, Miller, FW, Dobberstein, B and High, S, Human autoantibodies against the 54 kDa protein of the signal recognition particle block function at multiple stages. Arthritis Research & Therapy 2006; 8(2):R39.

 

2005

  1. Oddis, CV, Rider, LG, Reed, AM, Ruperto, N, Brunner, H, Koneru, B, Feldman, BM, Giannini, EH, and Miller, FW for the International Myositis Assessment and Clinical Studies Group (IMACS), International consensus guidelines for therapeutic trials in the idiopathic inflammatory myopathies. Arthritis Rheum 2005; 52(9):2607-2615.

  2. O'Hanlon, TP, Mercatante-Carrick, D, Targoff, IN, Arnett, FC, Reveille, J, Carrington, M, Gao, X, Oddis, CV, Morel, P, Malley, JD, Malley, K, Shamim, E, Rider, LG, Chanock, SJ, Foster, C, Bunch, T, Blackshear, PJ, Plotz, PH, Love, LA, Miller, FW, Immunogenetic Risk and Protective Factors for the Idiopathic Inflammatory Myopathies: Distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 Allelic Profiles Distinguish European American Patients With Different Myositis Autoantibodies. Medicine (Baltimore) 2006; 85(2):111-127.

  3. Chung, Y-L, Rider, LG, Bell, JD, Summers, RM, Zemel, LS, Rennebohm, RM, Passo, MH, Hicks, J, Miller, FW, Scott, DL, for the Juvenile Dermatomyositis Disease Activity Collaborative Study Group, Muscle metabolites, detected in urine by proton spectroscopy, correlate with disease damage in juvenile idiopathic inflammatory myopathies. Arthritis Rheum 2005; 53(4):565-70.

  4. Sarkar, K, Weinberg CR, Oddis, CV, Medsger, TA, Plotz, PH, Reveille, JD, Arnett, FC, Targoff, IN, Genth, E, Love, LA, Miller, FW, Seasonal influence in the onset of idiopathic inflammatory myopathies. Arthritis Rheum 2005; 52(8):2433-8.

 

2004

  1. Sarkar K, Miller FW, Possible roles and determinants of microchimerism in autoimmune and other disorders. Autoimmun Rev 2004 Aug; 3(6):454-63.

  2. Rider LG, Giannini EH, Brunner HI, Ruperto N, James-Newton L, Reed AM, Lachenbruch PA, Miller FW; International Myositis Assessment and Clinical Studies Group, International consensus on preliminary definitions of improvement in adult and juvenile myositis. Arthritis Rheum 2004 Jul; 50(7):2281-90. [Abstract] 

  3. Rennebohm RM, Jones K, Huber AM, Ballinger SH, Bowyer SL, Feldman BM, Hicks J, Katona IM, Lindsley CB, Miller FW, Passo MH, Perez MD, Reed AM, Wallace CA, White PH, Zemel LS, Lachenbruch PA, Hayes JR, Rider LG; Juvenile Dermatomyositis Disease Activity Collaborative Study Group, Normal scores for nine maneuvers of the Childhood Myositis Assessment Scale. Arthritis Rheum 2004 Jun; 15;51(3):365-70.

  4. Huber AM, Feldman BM, Rennebohm RM, Hicks JE, Lindsley CB, Perez MD, Zemel LS, Wallace CA, Ballinger SH, Passo MH, Reed AM, Summers RM, White PH, Katona IM, Miller FW, Lachenbruch PA, Rider LG; Juvenile Dermatomyositis Disease Activity Collaborative Study Group, Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies. Arthritis Rheum 2004 May; 50(5):1595-603.

 

2003

  1. Artlett CM, O'Hanlon TP, Lopez AM, Song YW, Miller FW, Rider LG, HLA-DQA1 is not an apparent risk factor for microchimerism in patients with various autoimmune diseases and in healthy individuals. Arthritis Rheum 2003 Sep; 48(9):2567-72.

  2. Okada S, Weatherhead E, Targoff IN, Wesley R, Miller FW; International Myositis Collaborative Study Group, Global surface ultraviolet radiation intensity may modulate the clinical and immunologic expression of autoimmune muscle disease. Arthritis Rheum 2003 Aug; 48(8):2285-93.

  3. Ruperto N, Ravelli A, Murray KJ, Lovell DJ, Andersson-Gare B, Feldman BM, Garay S, Kuis W, Machado C, Pachman L, Prieur AM, Rider LG, Silverman E, Tsitsami E, Woo P, Giannini EH, Martini A, For The Paediatric Rheumatology International Trials Organisation (PRINTO), The Pediatric Rheumatology Collaborative Study Group (PRCSG), Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. Rheumatology (Oxford) 2003 Jun 27 ; 000.

  4. Rider LG, Giannini EH, Harris-Love M, Joe G, Isenberg D, Pilkington C, Lachenbruch PA, Miller FW; International Myositis Assessment and Clinical Studies Group, Defining Clinical Improvement in Adult and Juvenile Myositis. J Rheumatol 2003 Mar; 30(3):603-17.

  5. Rider LG, Outcome assessment in the adult and juvenile idiopathic inflammatory myopathies. Rheum Dis Clin North Am 2002 Nov; 28(4):935-77.

 

2002

  1. Herdon TM, Yuang-Taung J, Solomou EE, Rothwell SW, Gourley MF, Tsokos GC, Direct transfer of p65 into T lymphocytes from systemic lupus erythematosus patients leads to increased levels of interleukin-2 promoter activity. Clin Immunol 2002; 103: 145-153.

  2. O'Hanlon, T.P. and Miller, F.W., Genomic Organization, Transcriptional Mapping, and Evolutionary Implications of the Human Bi-directional Histidyl-tRNA Synthetase Locus (HARS / HARSL). Biochemical and Biophysical Research Communications 2002; 294: 609-614.

  3. Shamim, EA, LG Rider, JP Pandey, TP O'Hanlon, LJ Jara, E Samayoa, R Burgos-Vargas, J Vazquez-Mellado, J Alcocer-Varela, M Salazar-Paramo, AG Kutzbach, JD Malley, IN Targoff, I Garcia de la Torre, and FW Miller, Idiopathic Inflammatory Myopathy Phenotypes and Genotypes Differ in Mesoamerican Mestizos and North American Caucasians: Ethnogeographic Influences in the Genetics and Clinical Expression of Myositis. Arthritis Rheum 2002; 46 (7): 1885-1893.

2001

  1. Illei, G.G., Austin, HA., Crane, M., Collins L., Gourley, M.F., Yarboro, C.H., Vaughan, E.M., Kuroiwa, T., Danning, C.L., Steinberg, A.D., Klippel, J.H., Balow, J.E., Boumpas, D.T., Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis. Ann Int Med 2001; 135:248-257.

  2. Miller, FW, Inflammatory Myopathies: Polymyositis, dermatomyositis, and related conditions. In Arthritis and Allied Conditions, A Textbook of Rheumatology, 14th Edition, Lippincott, Williams and Wilkins, Philadelphia, W. Koopman, editor 2001; Chapter 78, 1562-1589 (volume 2).

 

2000

  1. Artlett CM, Ramos R, Jiminez SA, Patterson K, Miller FW and Rider LG, Chimeric cells of maternal origin in juvenile idiopathic inflammatory myopathies. Lancet 2000; 356: 2155-2156.

  2. O'Hanlon, T.P., Lawless, O.J., Katzin, W.E., Feng, L.J., and Miller, F.W., Restricted and Shared Patterns of TCR beta-chain Gene Expression in Silicone Breast Implant Capsules and Remote Sites of Tissue Inflammation. Journal of Autoimmunity 2000; 14: 247-257.

  3. Miller FW, Hess EV, Clauw DW, Hertzman PA, Pincus T, Silver RM, Mayes MD, Varga J, Medsger TA, and Love LA, Approaches for identifying and defining environmentally associated rheumatic disorders. Arthritis Rheum 2000; 43:243-249.

  4. Rider LG, Artlett CM, Foster CB, Ahmed A, Neeman T, Chanock SJ, Jimenez SA and Miller FW, Polymorphisms in the interleukin-1 receptor antagonist VNTR are possible risk factors for juvenile idiopathic inflammatory myopathies. Clin ExpImmunology 2000; 121:47-52.

  5. Rider LG and Targoff IN, Single organ systems and autoimmunity: Muscle Diseases. Textbook of Autoimmune Diseases, ed. R.G. Lahita, N. Chiorazzi, W.H. Reeves. Lippincott- Raven, Philadelphia, PA 2000; Pg 429 - 474.

  6. Shamim E, Rider LG, and Miller FW, Genetic risk factors for the idiopathic inflammatory myopathies. Current Opinion Rheumatol 2000; 12: 482-91.

Back to Top